Divozilimab Antibody
Divozilimab (BCD-132) is a humanized anti-CD20 monoclonal antibody used in multiple sclerosis research. Its application includes investigating B-cell depletion mechanisms in both in vitro assays and in vivo experimental models relevant to autoimmune neuroinflammatory diseases.
Product Specifications
Target
Immunology/Inflammation related
Clonality
Monoclonal
Conjugation
Unconjugated
Field of Research
Immunology & Inflammation
Concentration
5.34 mg/mL
Purity
95.00% (May vary between batches)
Molecular Weight
145.36 kDa (Predicted)
Storage Conditions
Maintain refrigerated at 2-8°C for up to 2 weeks. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles.
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog